Strategic partnerships Bionovis has active and growing collaboration with Bahiafarma, Biocon Limited, Fiocruz, and Samsung Bioepis over recent years, including joint development and PDP programs that secure long-term supply and production capacity for complex biopharmaceuticals like Pertuzumab, presenting clear entry points for co-development, technology transfer, and contract manufacturing opportunities.

Public sector focus The company aligns with national public health initiatives and productive development partnerships to supply biosimilars and biopharmaceuticals to Brazil’s public systems, creating multiple procurement channels and potential volume-led sales opportunities through government programs.

Product pipeline Bionovis is actively building a pipeline that includes biosimilars, biobetters, and innovative biologics such as monoclonal antibodies and therapeutic proteins, offering cross-sell opportunities to expand product offerings in oncology and other high-need areas.

Global tech footprint Investment in a world-class bio manufacturing and digital ecosystem (AWS, Power BI, AutoCAD, 3D design, cloud services, data analytics) supports scalable production and data-driven operations, enabling targeted technical collaborations, GMP-grade manufacturing, and optimization services for potential partners.

Market positioning As a 100% Brazilian biopharma focused on high-complexity biologics, Bionovis is well-placed to capitalize on domestic PDP incentives, local manufacturing capabilities, and regional partnerships, presenting an opportunity to offer strategic manufacturing, regulatory, and access-focused solutions to similar regional players seeking local production.